one hundred twenty-nine patients with new york heart association class ii , iii , or iv congestive heart failure were randomized to receive either lisinopril 5 mg/day ( n = 64 ) or captopril 37.5 mg/day ( n = 65 ) in 15 centers .
C0018802
congestive heart failure
C0006938
captopril